SCHEMBL24959068

SCHEMBL24959068

CC(C)c1ncc(-c2cnn(C3CC3)c2)s1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM5B Q9UGL1 2/20 0.46
PIK3CD O00329 1/20 0.40
PIK3CA P42336 1/20 0.40
PIK3CB P42338 1/20 0.40
PI4KA P42356 1/20 0.40
PIK3CG P48736 1/20 0.40
PI4KB Q9UBF8 1/20 0.40
KDM5A P29375 2/20 0.39
CHRNB2 P17787 3/20 0.39
CHRNA4 P43681 3/20 0.39
RET P07949 1/20 0.38
LOXL2 Q9Y4K0 2/20 0.36
JAK2 O60674 2/20 0.35
ACHE P22303 1/20 0.35
IRAK4 Q9NWZ3 2/20 0.34
CYP1A2 P05177 2/20 0.34
CYP3A4 P08684 2/20 0.34
CYP3A5 P20815 2/20 0.34
CYP3A7 P24462 2/20 0.34
CYP2C19 P33261 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24956329 0.87 PIM1 (0.43) KDM5BKDM5ACHRNB2CHRNA4JAK2
SCHEMBL24956350 0.80 FLT3 (0.43) KDM5BPIK3CDPIK3CAPIK3CBPI4KA
SCHEMBL24958873 0.79 HDAC6 (0.41) KDM5BPIK3CDPIK3CAPIK3CBPI4KA
SCHEMBL24956347 0.78 KDM5B (0.40) KDM5BPIK3CDPIK3CAPIK3CBPI4KA
SCHEMBL24958876 0.76 KDM5B (0.48) KDM5BPIK3CDPIK3CAPIK3CBPI4KA
SCHEMBL24956527 0.73 ACHE (0.33) KDM5BPIK3CDPIK3CAPI4KAPIK3CG
SCHEMBL17806588 0.71 PIK3CD (0.46) KDM5BPIK3CDPIK3CAPIK3CBPI4KA
SCHEMBL21610561 0.69 ALDH1A1 (0.31)
SCHEMBL24958703 0.68 NTRK1 (0.41) KDM5BCHRNB2CHRNA4JAK2IRAK4
SCHEMBL24956356 0.65 KDM5B (0.34) KDM5BPIK3CDPIK3CAPIK3CBPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230021705-A1 GLP-1R MODULATING COMPOUNDS GILEAD SCIENCES, INC. 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230021705-A1 GLP-1R MODULATING COMPOUNDS GLP1R, GIPR, GPR119 KDM5B 2572/4885PIK3CD 778/4885PIK3CA 698/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.